48
Views
77
CrossRef citations to date
0
Altmetric
Research Article

The Clinical Biochemistry of Aluminum

, , &
Pages 1-20 | Published online: 27 Sep 2008

References

  • Alfrey A. C., Legendre G., Kaehny W. D. The dialysis encephalopathy syndrome possible aluminum intoxication. N. Eng. J. Med. 1976; 298: 184
  • Alfrey A. C. Dialysis encephalopathy syndrome. Ann. Rev. Med. 1978; 29: 93
  • Elliott H. L., MacDougall A. I., Fell G. S., Gardiner P. H.E. Plasmaphereses, aluminum and dialysis dementia. Lancet 1978; 2: 1255
  • Parkinson I. S., Feest T. G., Ward M. K., Fewcett R. W.P. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1979; 1: 406
  • Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in alzheimer's Disease and experimental neurofibrillary degeneration. Science 1973; 180: 511
  • McDermott J. R., Smith A. I. Brain aluminum concentration in dialysis encephalopathy. Lancet 1978; 1: 901
  • Berlyne G. M., Pest D., Ben-Ari J., Weinberger J., Stern M., Gilmore G. R., Levine R. Hyperaluminaemia from aluminum resins in renal failure. Lancet 1970; 2: 494
  • Kechny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J. Lab. Clin. Med. 1977; 296: 1389
  • Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J. Lab. Clin. Med. 1977; 92: 810
  • Kaehny W. D., Alfrey A. C., Holman R. E., Shorr W. J. Aluminum transfer during hemodialysis. Kidney Int. 1977; 12: 361
  • Kovalchik M. T., Kaehny W. D., Hegg A. P., Jackson J. T., Alfrey A. C. Aluminum kinetics during hemodialysis. J. Lab. Clin. Med. 1978; 92: 712
  • Garmestani K., Blotcky A. J., Rack E. P. Comparison between neutron activation analysis and graphite furnace atomic absorption spectrometry for trace aluminum determination in biological materials. Anal. Chem. 1978; 50: 144
  • Terai M., Hata S., Nishii Y. An application of activation analysis of aluminum in biological materials. Radioanal. Chem. 1977; 37: 599
  • Blotcky A. J., Hobson D., Leffler J. A., Rack E. P., Recker R. R. Determination of trace aluminum in urine by neutron activation analysis. Anal. Chem. 1976; 48: 1084
  • Ihnat M. Flame atomic emission spectrometric determination of aluminum in a bovne blood plasma matrix. Anal. Biochem. 1976; 73: 120
  • Alderman F. R., Gitelman H. J. Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin. Chem. 1980; 26: 258
  • Gorsky J. E., Deitz A. A. Determination of aluminum in biological samples by atomic absorptio spectrometry with a graphite furnace. Clin. Chem. 1978; 24: 1485
  • Arieff A. I., Cooper J. D., Armstrong D., Lazarowtiz V. C. Dementia, renal failure and brain aluminum. Ann. Intern. Med. 1979; 90: 741
  • Spofforth J. Case of aluminum poisoning. Lancet 1921; 1: 1301
  • Betts C. T. Aluminum Poisoning. Research Publishing Co., Toledo, Ohio 1926
  • Kehoe R. A., Cholak J., Story R. V. A spectrochemical study of the normal ranges of concentration of certain trace metals in biological materials. J. Nutr. 1940; 19: 579
  • Klatzo I., Wisniewski H., Streicher E. Experimental production of neurofibrillary degeneration. I. Light microscope observations. J. Neuropathology. Exp. Neurol. 1965; 24: 187
  • Parsons V., Davies C., Godde C., Ogg C., Siddiqui J. Aluminum in bone from patients with renal failure. Br. Med. J. 1971; 4: 273
  • Clarkson E. M., Luck V. A., Hynson W. V., Bailey R. R., Eastwood J. B., Woodhead J. S., Clements V. R., O'Riordan J. L. H., DeWardener H. E. The effect of aluminum hydroxide on calcium, phosphorus, and aluminum balances; the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure. Clin. Sci. 1972; 43: 519
  • Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Randolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans. Am. Soc. Artif. Intern. Organs. 1972; 18: 257
  • Berlyne G. M., Ben-Ari J., Knopf E., Yagil R., Weinberger G., Danovitch G. M. Aluminum toxicity in rats. Lancet 1972; 1: 564
  • Cam J. M., Luck V. A., Eastwood J. B., DeWardner H. E. The effect of aluminum hydroxide orally on calcium, phospnhorus, and aluminum in normal subjects. Clin. Sci. Mol. Med. 1976; 51: 407
  • Gosrsky J. E., Dierz A. A., Spencer H., Osis D. Metabolic balance of aluminum. Clirt. Chem. 1979; 25: 1739
  • Myor G. H., Keiser J. A., Makdani D., Ku P. K. Aluminum absorption and distribution: efect of parathroid hormone. Science 1977; 197: 1187
  • Salvadeo A., Minoia C., Segagni S., Villa G. Trace metal changes absorption and distribution: effect of parathroid hormone. Science 1979; 197: 1187
  • Allain P., Thebaud H. E., Dupouet L., Coville P., Pisant M., Spiesser J., Alquier P. Study of blood levels of a number of metals (Al, Mn, Cd, Pb, Cu, Zn) in chronic hemodialyosis patients before and after dialysis. Nouv. Presse Med. 1978; 7: 92
  • Gacek E. M., Babb A. I., Urelli D. A., Fry D. L., Scribner B. H. Dialysis dementia: the role of dialyzate pH in altering the dializability of aluminum. Trans. Am. Soc. Artif. Intern. Organs 1979; 25: 409
  • Flendrig J. A., Kruis H., Das H. A. Aluminum nad dialysis dementia. Lancet 1976; 2: 1235
  • Lundin A. P., Caruso C., Sass M., Berlyne G. M. Ultrafiltrable aluminum in serum of normal man. Clin. Res. 1978; 26: 636A
  • Berlyne G. M. Plasmaphersis, aluminum and dialysis dementia. Lancet 1978; 2: 1155
  • Elliott H. L., MacDougall A. I., Haase G., Cumming R. L. C., Gardner P. H. E., Fell G. S. Plasmapheresis in the treatment of dialysis encephalopathy. Lancet 1978; 2: 940
  • King S. W., Wills M. R., Savory J. Serrum binding of alu minus. Res. Commun. Chem. Pathol. pharmacol. 1961; 26: 161
  • Dent C. E., Harper C. M., Philpot G. R. The treatment of renaglometrular osteodystrophy. Q. J. Med. 1961; 30: 1
  • Dent C. E., Winter C. S. Osteomalacia due to phosphate depletion from excessive aluminum hydroxide ingestion. Br. Med. J. 1974; 1: 551
  • Baker L. R. I., Akcrill P., Cattell W. R., Stamp T. C. B., Waston L. Iatrogenic ostemalacid and myopathy due to phosphate depletion. Br. Med. J. 1974; 3: 150
  • Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fratures and encephalopthy in patients on home dialysis. Br. Med. J. 1977; 2: 657
  • Ward M. K. H. A., Ellis H. A., Feest T. G., Parkinson I. S., Kerr D. N. S. Osteomalacic dialysis ostedystrophy: Evidence for a water-borne aetiological agent, probably aluminum. Lancet 1978; 1: 841
  • Cournot-Witmer G., Zingraff J., Bourdon R., Druëke T., Balsan S. Aluminum and dialysis bone disease. Lancet 1979; 2: 795
  • Burks J., Huddlestone J., Lewin E., Alfrey A., Rudolph H. A progressive encephalopathy in chronic dialysis patients. Neurology 1974; 24: 359
  • Baratt L. A., Lawrence J. R. Dialysis-associated dementia. Aust. N. Z. J. Med. 1975; 5: 62
  • Wardle E. N. Dialysis dementia. Lancet 1973; 2: 47
  • Mahurkar S. D., Salta R., Smith E. C., Dhar S. K., Meyres L. Jt., Duneas G. Dialysis dementia. Lancet 1973; 1: 1412
  • Buge A., Escourolle R., Poisson M., Gray F., Bleibel J. M., Jaudon M. C. Progressive dialytic encephalopathy. Role of the aluminum and neorological study. Nouv. Presse Med. 1979; 8: 1071
  • Duenea G., Mahurkar S. D., Mamdani B., Smith E. C. Role of aluminium in dialysis dementia. Ann. Intern. Med. 1978; 88: 502
  • Mahukar S. D., Smith E. C., Mamdani B. H., Dunea G. Dialysis dementia. The Chicago experience. J. Dialysis 1978; 2: 447
  • Rozas V. V., Port F. K.J., Rutt W. M. Progressive dialysis encephalopathy from dialysate aluminum. Arch. Int. Med. 1978; 138: 1375
  • Elliott H. L., Dryburgh F., Fell G. S., Sabet S., MacDougall A. I. Aluminum toxicity during regular haemodialysis. Br. Med. J. 1978; 1: 1101
  • Nadel A. M., Wilson W. P. Dialysis encephalopathy: A possible seizure diorder. Neorology 1976; 26: 1130
  • Snider W. D., DeMaria A. A., Jr., Mann J. D. Diazepam and dialysis encephalopathy. Neurology 1979; 29: 414
  • Masselot J. P., Adhemar J. P., Jaudon M. C., Kleinknecht D., Galli A. Reversible dialysis encephalopathy: Role for aluminum-containing gels. Lancet 1978; 2: 1386
  • Poisson M., Mashaly R., Lebkiri B. Dialysis dementia: recovery after transplatation. Br. Med. J. 1978; 2: 1610
  • Buge A., Poisson M., Mason S., Bliebel J. M., Mashlay R., Jaudon M. C., Lafforgue B., Lebkiri M., Raymond P. Reversible dyalitic encephalopathy after interruption of aluminum uptake. Nouv. Presse Med. 1979; 8: 2729
  • Sullivan P. A., Murnaghan D. J., Callaghan N. Dialysis dementia: recovery after transplatation. Br. Med. J. 1977; 2: 740
  • Burks J. S., Huddlestone J., Alfrey A. C., Noreberg M. D., Levin E. A fatal encephalopathy in chronic haemodialysis in patients. Lancet 1978; 1: 764
  • Graf H., Stummvoll H. K., Meisinger V., Kovasrik J., Wolf A., Pinggera W. F. Aklumnum in haemodialysis. Lancet 1979; 1: 379
  • Galle P., Chatel M., Berry J. P., Menault F. Progressive myoclonic encephalopathy in dialysis patiets: presense of high concentrations of aluminum in the lysosomes of cerebral cells. Nouv. Presse Med. 1979; 24: 4091
  • De Boni U., Scott J. W., Crapper D. R. Intracellular aluminum binding: a histochemical study. Histochemistry 1974; 40: 31
  • Womack F. C., Colowick S. P. Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations. Proc. Natl. Acad. Sci. U. S. A. 1979; 76: 5080
  • Lai J. C., Guest J. F., Leung T. K. C., Lim L., Davison A. N. The effects of cadmium, manganess, and aluminum on sodium-potassium-activated and magnesium-activated adenosine triphorphatase activity and choline uptake in rat synatosomes. Biochem. Pharmacol. 1980; 29: 141
  • Bòone I., Thomas M. Dialysis demedntia, aluminum, land tetrahydrobiotern metabolism. Lancet 1979; 1: 782
  • Leeming R. J., Blair J. A. Dialysis dementia, aluminum, land tetrahydrobioptern metabolism. Lancet 1979; 1: 559
  • Cameron K. R., Birchall S. M., Moses M. A. Isolation of foamy virus from patient with dialysis encephalopathy. Lancet 1978; 2: 796
  • Mahurkar S. D., Meyers L., Jr., Cohen J., Kamath R. V., Dunea G. Electroencephalograhic and radionucleotide studies in dialysis dementia. Kidney Int. 1978; 13: 306
  • Crapper D. R., De Boni U. Brain aging and Alzeheimer's Disease. Can. Psychiatr. Assoc. J. 1978; 23: 229
  • Trapp G. A., Miner G. D., Zimmerman R. L., Mastri A. R., Heston L. L. Aluminum levels in brain in Alzheimer's Disease. Biol. Psychiatry 1978; 13: 709
  • Terry R. D., Pe˜na C. Experimental production of neurofibrillary degeneration. II. Electron microscopy, phospahtasa histochemistry and electron-probe analysis. J. Neuropathol. Exp. Neurol. 1965; 24: 200
  • Craper D. R., Krishan S. S., quittakat S. Aluminum, neorofibrillary degeneration and Alzheimer's Disease. Brain 1976; 99: 67
  • Tipton I. H., Cook M. J., Foland J. M., Rittner J., Hardwich M., McDaniel K. K. Oak Ridge Nat. Lab. Rep. Oak Ridge, Tenn. 1959, Central File No. 59–8-106
  • McLaughlin A. I. G., Kazatizis G., King E., Tears D., Porter R. J., Owne R. Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. Br. J. Ind. Med. 1962; 19: 253
  • Crapper D. R., Karlik S., De Boni U. Aluminum and other metals in senile (Alzheimer) dementia. Aging, R. Katzman, R. D. Terry, K. L. Bick. Raven Press, New York 1976; Vol. 7: 471
  • Crapper D. R. Funcitonal consequences of neurofibrillary degeneration. Neurobiology of Agin, R. D. Perry, S. Gershon. Raven Press, New York 1976; 405
  • Iqbal K., Grundke-Iqbal I., Wisnieski H. M., Korthals J. K., Terry R. D. Chemistry of neurofibrous proteins in aging. Neurobiology of Aging, R. D. Terry, S. Gershon. Raven Press, New York 1976; 351
  • Petit T. L., Biederman G. B., McMuellen P. A. Neurofibrillary degeneration, dendritic dying back and learning-memory deficiets after alumium administration: Implications for brain aging. Exp. Neurol. 1980; 67: 152

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.